¼¼°èÀÇ µ¿¹°¿ë ¹é½Å ½ÃÀå ¿¹Ãø(2025-2030³â)
Veterinary Vaccines Market - Forecasts fom 2025 to 2030
»óǰÄÚµå : 1800223
¸®¼­Ä¡»ç : Knowledge Sourcing Intelligence
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 151 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,950 £Ü 5,567,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,550 £Ü 6,413,000
PDF (Multiple User License) help
PDF º¸°í¼­¸¦ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,796,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ µ¿¹°¿ë ¹é½Å ½ÃÀåÀº CAGR 8.02%·Î È®´ëµÇ¾î 2025³â 93¾ï 5,400¸¸ ´Þ·¯¿¡¼­ 2030³â±îÁö 137¾ï 5,800¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

µ¿¹°¿ë ¹é½Å ½ÃÀåÀº 2025³âºÎÅÍ 2030³â±îÁö Å« ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖÀ¸¸ç, ±× ¿øµ¿·ÂÀº ÀÎÃà °øÅë °¨¿°ÁõÀÇ À¯Çà, ¼¼°è ¹Ý·Áµ¿¹° »çÀ° Áõ°¡, Ãà»ê Á¦Ç° ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. ¾àµ¶»ý ¹é½Å, ºÒȰ¼ºÈ­ ¹é½Å, À¯ÀüÀÚ ÀçÁ¶ÇÕ ¹é½Å µîÀ» Æ÷ÇÔÇÑ µ¿¹°¿ë ¹é½ÅÀº ¹Ý·Áµ¿¹° ¹× ³ó¾÷ µ¿¹°ÀÇ Áúº´ °¨¿°À» ¿¹¹æÇÏ°í µ¿¹°°ú Àΰ£ÀÇ °Ç°­À» º¸È£ÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ·Î ºñ°æ±¸ÀûÀÎ ¹æ½ÄÀ¸·Î Åõ¿©µÇ´Â ÀÌµé ¹é½ÅÀº µ¿¹° °Ç°­ °ü¸® »ê¾÷¿¡¼­ ÇʼöÀûÀÔ´Ï´Ù. ¾ö°ÝÇÑ ±ÔÁ¦°¡ °úÁ¦°¡ µÉ ¼ö ÀÖÁö¸¸, ½ÃÀåÀº Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ¿¹¹æ ÇコÄɾî·ÎÀÇ ½ÃÇÁÆ®¿¡ ÀÇÇØ Áö¿øµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

Àμö °øÅë °¨¿° Áõ°¡

Àμö °øÅë °¨¿° Áõ°¡´Â µ¿¹° ¹é½Å ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. µ¿¹°Àº ¹ÚÅ׸®¾Æ, ¹ÙÀÌ·¯½º, ±â»ýÃæ, °õÆÎÀÌ¿Í °°Àº º´¿øÃ¼¸¦ ¸Å°³ ÇÒ ¼ö ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ º´¿øÃ¼´Â °æÁõ¿¡¼­ Ä¡¸íÀûÀÎ °Í±îÁö Àΰ£¿¡°Ô ½É°¢ÇÑ Áúº´À» À¯¹ßÇÕ´Ï´Ù. Àμö °øÅë °¨¿°ÀÇ ¼¼°è ºÎ´ãÀº µ¿¹°¿¡¼­ Àΰ£À¸·ÎÀÇ °¨¿°À» ¹æÁöÇÏ´Â È¿°úÀûÀÎ µ¿¹° ¹é½ÅÀÇ Çʿ伺À» °­Á¶ÇÕ´Ï´Ù. µ¿¹° ¹ÙÀÌ·¯½º ¹ß»ýÀ» ´ë»óÀ¸·Î ÇÑ ÇÁ·Î±×·¥°ú °°Àº Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê´Â ÁÖ¿ä ¿¹¹æ Á¶Ä¡·Î ¿¹¹æ Á¢Á¾À» ÃËÁøÇÔÀ¸·Î½á ½ÃÀå ¼ºÀåÀ» ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ³ë·ÂÀº Àμö °øÅë °¨¿°ÀÇ À§ÇèÀÌ Áõ°¡ÇÏ´Â °¡Ãà°ú ¹Ý·Áµ¿¹° ¼ö°¡ ¸¹Àº Áö¿ª¿¡¼­ ƯÈ÷ Áß¿äÇÕ´Ï´Ù.

Àεµ ¼ö¿ä Áõ°¡

ÀεµÀÇ µ¿¹°¿ë ¹é½Å ½ÃÀåÀº Àα¸ Áõ°¡¿Í ½Ä»ýȰ º¯È­¿¡ ÈûÀÔ¾î ½ÄÀ°°ú À¯Á¦Ç° µî Ãà»ê¹°¿¡ ´ëÇѼö¿ä°¡ ³ô¾ÆÁü¿¡ µû¶ó ²ÙÁØÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀεµÀÇ ³ó¾÷°æÁ¦¿¡ Å©°Ô °øÇåÇϰí ÀÖ´Â °¡±Ý·ù¿Í ³«³ó ºÐ¾ß¿¡¼­´Â °¨¿°ÁõÀ» ¿¹¹æÇÏ°í °Ç°­ÇÑ °¡ÃàÀ» È®º¸Çϱâ À§ÇØ ¹é½ÅÀÇ µµÀÔÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù. ¿¹¹æ Á¢Á¾ÀÇ °æÁ¦Àû ÀÌÀÍ¿¡ ´ëÇÑ ³óºÎÀÇ ÀÇ½Ä Áõ°¡¿Í ±¹°¡ µ¿¹° Áúº´ °ü¸® ÇÁ·Î±×·¥°ú °°Àº Á¤ºÎ ÇÁ·Î±×·¥Àº ½ÃÀå È®´ë¸¦ Áö¿øÇÕ´Ï´Ù.¼ö¿ä°¡ ³ôÀº ¹é½ÅÀº °¡ÃàÀÇ °Ç°­¿¡ ÁßÁ¡À» ¹Ý¿µÇÏ¿© ÀÛÀº µ¿¹°ÀÇ ¿ªº´(PPR), ºê·ç¼¿¶ó±Õ, ±¸Á¦¿ª(FMD)À» À§ÇÑ ¹é½ÅÀ» Æ÷ÇÔÇÕ´Ï´Ù.

¹Ý·Áµ¿¹° »çÀ° Áõ°¡

¹Ý·Áµ¿¹°ÀÇ »çÀ°·üÀº ¼¼°èÀûÀ¸·Î »ó½ÂÇϰí ÀÖÀ¸¸ç, ƯÈ÷ °³¿Í °í¾çÀÌ¿Í °°Àº ¹Ý·Áµ¿¹°ÀÇ »çÀ°·üÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ µ¿ÇâÀº ÁÖÀÎÀÌ ¹Ý·Áµ¿¹°À» º¸È£Çϰí Áü½Â °øÅë °¨¿°ÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ ¿¹¹æ ÀÇÇÐÀ» ¼±È£Çϱ⠶§¹®¿¡ ¹Ý·Áµ¿¹° °ü¸® ÁöÃâ Áõ°¡¸¦ ¼ö¹ÝÇÕ´Ï´Ù. ƯÈ÷ °í¾çÀÌÀÇ Àαâ Áõ°¡´Â ÁÖÀÎÀÌ µ¿¹°ÀÇ °Ç°­°ú ¾ÈÀüÀ» º¸ÀåÇϱâ À§ÇØ ¹é½ÅÀ» ¿ä±¸Çϱ⠶§¹®¿¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÕ´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

µ¿¹°¿ë ¹é½Å ½ÃÀåÀº ¹é½Å ½ÂÀο¡ °üÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ Á¤Ã¥¿¡ µû¸¥ °úÁ¦¿¡ Á÷¸éÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ÁøÀÔÀ» Áö¿¬½ÃŰ°í ½ÃÀå °³Ã´ ºñ¿ëÀ» Áõ°¡½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦´Â ¾ÈÀü°ú È¿À²¼ºÀ» º¸ÀåÇÏ´Â ¹Ý¸é, ƯÈ÷ ¼Ò±Ô¸ð Á¦Á¶¾÷üÀÇ °æ¿ì ±â¼ú Çõ½Å°ú Á¢±Ù¼ºÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ °í±Þ ¹é½Å °¡°ÝÀÌ ³ô±â ¶§¹®¿¡ °³¹ßµµ»ó±¹°ú °°Àº °¡°Ý¿¡ ¹Î°¨ÇÑ ½ÃÀå¿¡¼­´Â µµÀÔÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ±ÔÁ¦ ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÏ°í ºñ¿ë È¿À²ÀûÀÎ ¹é½Å °³¹ßÀ» ÅëÇØ ÀÌ·¯ÇÑ °úÁ¦¸¦ ÇØ°áÇÏ´Â °ÍÀº ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀå¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå ÇöȲ

Á¦3Àå ºñÁî´Ï½º »óȲ

Á¦4Àå ±â¼ú Àü¸Á

Á¦5Àå µ¿¹°¿ë ¹é½Å ½ÃÀå : ¹é½Å À¯Çüº°

Á¦6Àå µ¿¹°¿ë ¹é½Å ½ÃÀå : Åõ¿© ¹æ¹ýº°

Á¦7Àå ¼öÀÇ ¹é½Å ½ÃÀå : µ¿¹° À¯Çüº°

Á¦8Àå µ¿¹°¿ë ¹é½Å ½ÃÀå : Áö¿ªº°

Á¦9Àå °æÀï ȯ°æ°ú ºÐ¼®

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦11Àå ºÎ·Ï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The veterinary vaccines market is expected to grow from USD9.354 billion in 2025 to USD13.758 billion in 2030, at a CAGR of 8.02%.

The veterinary vaccines market is projected to experience significant growth from 2025 to 2030, driven by the rising prevalence of zoonotic diseases, increasing global pet adoption, and growing demand for livestock products. Veterinary vaccines, including live attenuated, inactivated, recombinant, and other types, are critical for preventing disease transmission in companion and agricultural animals, protecting both animal and human health. Administered primarily through parenteral methods, these vaccines are essential in the veterinary healthcare industry. The market is supported by government initiatives and a shift toward preventive healthcare, though stringent regulations may pose challenges.

Market Drivers

Rising Zoonotic Diseases

The increasing incidence of zoonotic diseases is a primary driver of the veterinary vaccines market. Animals can transmit pathogens such as bacteria, viruses, parasites, and fungi, which cause serious illnesses in humans, ranging from mild to fatal. The global burden of zoonotic diseases underscores the need for effective veterinary vaccines to prevent transmission from animals to humans. Government initiatives, such as programs targeting animal virus outbreaks, further boost market growth by promoting vaccination as a key preventive measure. These efforts are particularly critical in regions with high livestock and pet populations, where zoonotic risks are elevated.

Growing Demand in India

The Indian veterinary vaccines market is experiencing steady growth, driven by rising demand for livestock products like meat and dairy, fueled by population growth and changing dietary habits. The poultry and dairy sectors, major contributors to India's agricultural economy, are increasingly adopting vaccines to prevent infectious diseases and ensure healthy animal populations. Farmers' growing awareness of the economic benefits of vaccination, coupled with government programs like the National Animal Disease Control Programme, supports market expansion. High-demand vaccines include those for Peste des petits ruminants (PPR), Brucella, and Foot and Mouth Disease (FMD), reflecting the focus on livestock health.

Increasing Pet Adoption

Global pet adoption rates are rising, particularly for companion animals like dogs and cats, driving demand for veterinary vaccines. This trend is accompanied by increased pet care expenditures, as owners prioritize preventive healthcare to protect their pets and reduce zoonotic risks. The growing popularity of cats, in particular, is contributing to market growth, as pet owners seek vaccines to ensure animal health and safety.

Market Restraints

The veterinary vaccines market faces challenges due to stringent regulatory policies governing vaccine approvals, which can delay market entry and increase development costs. These regulations, while ensuring safety and efficacy, may limit innovation and accessibility, particularly for smaller manufacturers. Additionally, the high cost of advanced vaccines can restrict adoption in price-sensitive markets, such as developing regions, where affordability is a key concern. Addressing these challenges through streamlined regulatory processes and cost-effective vaccine development will be critical for sustained market growth.

Market Segmentation

By Product Type

The market includes live attenuated, inactivated, recombinant, and other vaccines. Parenteral administration dominates due to its effectiveness in delivering targeted immunity. Recombinant vaccines are gaining traction for their precision and safety in addressing specific pathogens.

By Animal Type

The market serves companion animals (e.g., dogs, cats) and agricultural animals (e.g., cattle, poultry). The companion animal segment is growing rapidly due to rising pet ownership, while the agricultural segment remains significant, driven by the need to maintain livestock health and productivity.

By Geography

The market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America leads due to high pet care spending and advanced veterinary infrastructure. Asia-Pacific, particularly India, is expected to grow steadily, driven by increasing livestock production and government support. Europe, South America, and the Middle East and Africa are also poised for growth, supported by rising awareness and improving veterinary services.

The veterinary vaccines market is set for robust growth from 2025 to 2030, driven by rising zoonotic disease risks, growing pet adoption, and increasing demand for livestock products, particularly in India. Despite challenges from stringent regulations and high costs, the market's outlook remains positive, with strong growth in North America and Asia-Pacific. Industry players must focus on innovative, cost-effective vaccines and regulatory compliance to capitalize on the growing demand for preventive animal healthcare solutions.

Key Benefits of this Report:

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Segmentation:

By Vaccine Type

By Mode of Administration

By Animal

By Geography

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

3. BUSINESS LANDSCAPE

4. TECHNOLOGICAL OUTLOOK

5. VETERINARY VACCINE MARKET BY VACCINE TYPE

6. VETERINARY VACCINE MARKET BY MODE OF ADMINISTRATION

7. VETERINARY VACCINE MARKET BY ANIMAL TYPE

8. VETERINARY VACCINE MARKET BY GEOGRAPHY

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

10. COMPANY PROFILES

11. APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â